Literature DB >> 27630063

What we need to know about renal nerve ablation for treatment of hypertension and other states of sympathetic overactivity.

Markus P Schlaich1,2,3.   

Abstract

Renal nerves are key players in the regulation of kidney function and blood pressure control. Targeting the neurogenic mechanisms underlying hypertension and cardiac and renal disease has been attempted by means of surgical and pharmacologic approaches and most recently by catheter-based interventions aimed at disrupting renal sympathetic nerve traffic. The recent developments in the area and the relevant questions that need to be addressed to advance the field further are briefly reviewed in this article.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  blood pressure; cardiovascular disease; renal denervation; resistant hypertension; sympathetic overactivity

Mesh:

Year:  2016        PMID: 27630063     DOI: 10.1152/ajprenal.00058.2016

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  4 in total

Review 1.  Effects of Intrauterine Growth Restriction and Female Sex on Future Blood Pressure and Cardiovascular Disease.

Authors:  Gwendolyn K Davis; Ashley D Newsome; Norma B Ojeda; Barbara T Alexander
Journal:  Curr Hypertens Rep       Date:  2017-02       Impact factor: 5.369

Review 2.  [Renal denervation : Really an alternative to reducing blood pressure?]

Authors:  Kristina Striepe; Mario Schiffer; Roland Schmieder
Journal:  Internist (Berl)       Date:  2022-01-14       Impact factor: 0.743

3.  Renal perivascular adipose tissue: Form and function.

Authors:  Carolina Baraldi A Restini; Alex Ismail; Ramya K Kumar; Robert Burnett; Hannah Garver; Gregory D Fink; Stephanie W Watts
Journal:  Vascul Pharmacol       Date:  2018-02-15       Impact factor: 5.773

4.  Occupational stress and psychological health impact on hypertension of miners in noisy environment in Wulumuqi, China: a case-control study.

Authors:  Yaoqin Lu; Huan Yan; Jiandong Yang; Jiwen Liu
Journal:  BMC Public Health       Date:  2020-11-10       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.